Company profile: NJ Bio
1.1 - Company Overview
Company description
- Provider of integrated chemistry and biology CRO/CDMO services for biotech and pharma, including bioconjugation and antibody-drug conjugates, protein production, and cell-based assays. Offerings include express, standard, and custom conjugations for ADC assessment and validation, protein/peptide drug conjugates, and carrier protein conjugates for vaccines and antibody generation.
Products and services
- Standard Conjugation: Produces larger scale mAb conjugations with access to a broader range of validated linker–payloads for in vivo target validation, delivering reproducible antibody–drug conjugates (validated)
- Custom Conjugation: Tailored for preclinical development and lead optimization, allowing selection of the best bioconjugate based on the biology of the indication (custom-engineered)
- Express Conjugation: Delivers rapid assessment of ADC targets using approved linker–payloads and established conjugation techniques, generating well-characterized antibody–drug conjugates for early screening (accelerated)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NJ Bio
Mapi
HQ: France
Website
- Description: Provider of patient-centered research services to the global healthcare industry, serving academia, life science researchers, and the pharmaceutical industry for over 40 years.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mapi company profile →
Biotage
HQ: Sweden
Website
- Description: Provider of life science separation and analytical chemistry technologies, offering complete solutions for drug discovery and development—covering synthesis, purification and isolation of small and large molecules from lab to large-scale manufacturing—plus workflow solutions for bioanalytical, forensic toxicology, doping control, environmental and food testing, and bioprocessing purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotage company profile →
Gentronix
HQ: United Kingdom
Website
- Description: Provider of regulatory genotoxicity studies (GLP Ames, mouse lymphoma, in vitro micronucleus), predictive genotoxicity screening to detect liability early, skin toxicology assays for corrosion, irritation and sensitisation, and flow cytometry services. Includes Ames MPF/II and 24-well Agar formats requiring low test item amounts. Supports drug development and chemicals in cosmetics, personal care, and other chemistry driven industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentronix company profile →
LMC Manna Research
HQ: Canada
Website
- Description: Provider of Phase I-IV clinical trial services via Canada's largest network of fully owned and integrated clinical research sites, with specialized focus on endocrine disorders, RWE – Big Data, vaccine research, and primary care studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LMC Manna Research company profile →
Medivir
HQ: Sweden
Website
- Description: Provider of research-based pharmaceuticals focused on oncology and infectious diseases, leveraging protease inhibitor design and nucleotide/nucleoside science to address unmet medical needs. Portfolio includes MIV-818 for liver cancer, remetinostat for early-stage MF-CTCL, and VBX-1000 with positive proof-of-concept results. Also offers quarterly report conference calls and investor presentations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medivir company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NJ Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NJ Bio
2.2 - Growth funds investing in similar companies to NJ Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NJ Bio
4.2 - Public trading comparable groups for NJ Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →